For example, if HMOX1 repeat length only has phenotypic implications in the critically unwell patients with infection, we are limited to those patients in the UK Biobank who develop critical infection—an extremely heterogenous condition—while the only outcome measure we can reliably record is mortality. Here, HMOX1 is linked to infection.